Laureate Education
LAUR· Services· Fiscal year ends in December
CEO pay in FY2025Stock +84.1% in FY2025
Eilif Serck-Hanssen is the CEO of Laureate Education and was paid $11.0M in FY2025 (Dec), up 122%.
Pay$100 in the stock at the end of FY20 → $436
Executives4
See all- 1Eilif Serck-HanssenPresident and Chief Executive OfficerFY2025
- 2Marcelo Barbalho CardosoExecutive Vice President and Chief Operating OfficerFY2025
- 3Richard M. BuskirkSenior Vice President and Chief Financial OfficerFY2025
- 4Leslie S. BrushSenior Vice President, Chief Legal Officer and SecretaryFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allLaureate Education paid its 4 named executives $16.0M in total in FY2025 (Dec). CEO Eilif Serck-Hanssen was paid $11.0M of that.
| Name | |||
|---|---|---|---|
| Eilif Serck-HanssenPresident and Chief Executive Officer | |||
| Marcelo Barbalho CardosoExecutive Vice President and Chief Operating Officer | |||
| Richard M. BuskirkSenior Vice President and Chief Financial Officer | |||
| Leslie S. BrushSenior Vice President, Chief Legal Officer and Secretary | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Laureate Education. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Board3
See all- Ian K. SnowDirector · 18 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive
- George MuñozDirector · 12 yr on the boardIndependentAudit and Risk (Chair), Compensation—Paid as an executive
- William J. DavisDirector · 1 yr on the boardIndependentAudit and Risk—Paid as an executive
The board of the latest proxy (FY2025).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 9, 2026 | FY2025 |
| Annual report | 10-K | Feb 19, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 11, 2025 | FY2024 |
| Annual report | 10-K | Feb 20, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 19, 2024 | FY2023 |
| Annual report | 10-K | Feb 22, 2024 | FY2023 |